SB Investment Advisers (uk) Ltd., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 381,678 shares at $26.24 ($10.0M) on 2023-01-17, disclosed to the SEC on 2023-01-19.
Open-market sale of $10.0M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.24 | 88,372 | $2.3M | 23.1% |
| 2 | $26.24 | 88,372 | $2.3M | 23.1% |
| 3 | $26.31 | 102,467 | $2.7M | 26.9% |
| 4 | $26.31 | 102,467 | $2.7M | 26.9% |
| Total | $26.28 avg | 381,678 | $10.0M | 100% |
| Filing → |
| VIR | SELL | 2025-10-24 | $3.6M | — | Filing → |
| VIR | SELL | 2025-10-09 | $6.4M | — | Filing → |
| CPNG | SELL | 2025-06-17 | $282.5M | — | Filing → |